Cell Line : SK-N-BE(2)
Cellosaurus Index : CVCL_0528
Cellosaurus ID : SK-N-BE(2)
CCLE Name
: SKNBE2_AUTONOMIC_GANGLIA
CTRP2 Name
: SKNBE2
Cancer Type : autonomic_ganglia
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| SK-N-BE(2) | 16-beta-bromoandrosterone | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | 1S,3R-RSL-3 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | 3-Cl-AHPC | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | A-804598 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AA-COCF3 | CTRP2 | 0.0081 | 130.0000 |
|
| SK-N-BE(2) | ABT737 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | AC55649 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | AEW541 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | Afatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AGK-2 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Alisertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | alisertib:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | Alpelisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | alvocidib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AM-580 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | apicidin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ASN 05257430 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | AT-406 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AT13387 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AT7867 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | austocystin D | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | avicin D | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | avrainvillamide | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Axitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | azacitidine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AZD-7545 | CTRP2 | 0.0023 | 74.0000 |
|
| SK-N-BE(2) | AZD1480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AZD4547 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AZD6482 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AZD7762 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | AZD8055 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | B02 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | bafilomycin A1 | CTRP2 | 0.0000 | 0.3300 |
|
| SK-N-BE(2) | barasertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | bardoxolone methyl | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Bax channel blocker | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BCL-LZH-4 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Belinostat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | bendamustine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | betulinic acid | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Bexarotene | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BI-2536 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BIBR-1532 | CTRP2 | 0.0320 | 270.0000 |
|
| SK-N-BE(2) | birinapant | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BIX-01294 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | bleomycin A2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BMS-195614 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BMS-345541 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BMS-536924 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | BMS-754807 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Bortezomib | CTRP2 | 0.0000 | 0.1300 |
|
| SK-N-BE(2) | Bosutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-A02303741 | CTRP2 | 0.0017 | 55.0000 |
|
| SK-N-BE(2) | BRD-A02303741:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-A02303741:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | BRD-A05715709 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-A71883111 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD-A86708339 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K01737880 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K02251932 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K03536150 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | BRD-K04800985 | CTRP2 | 0.0020 | 67.0000 |
|
| SK-N-BE(2) | BRD-K07442505 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K11533227 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K13999467 | CTRP2 | 0.0020 | 67.0000 |
|
| SK-N-BE(2) | BRD-K14844214 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K17060750 | CTRP2 | 0.0020 | 67.0000 |
|
| SK-N-BE(2) | BRD-K19103580 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K24690302 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K26531177 | CTRP2 | 0.0100 | 330.0000 |
|
| SK-N-BE(2) | BRD-K28456706 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K29313308 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K30748066 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K33199242 | CTRP2 | 0.0020 | 67.0000 |
|
| SK-N-BE(2) | BRD-K33514849 | CTRP2 | 0.0010 | 34.0000 |
|
| SK-N-BE(2) | BRD-K34222889 | CTRP2 | 0.0017 | 57.0000 |
|
| SK-N-BE(2) | BRD-K35604418 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | BRD-K37390332 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD-K41597374 | CTRP2 | 0.0020 | 67.0000 |
|
| SK-N-BE(2) | BRD-K42260513 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K45681478 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K48477130 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K50799972 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K51490254 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K51831558 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K55116708 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K55473186 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K61166597 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K63431240 | CTRP2 | 0.0009 | 30.0000 |
|
| SK-N-BE(2) | BRD-K64610608 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD-K66453893 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K66532283 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K70511574 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K71781559 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K71935468 | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-BE(2) | BRD-K80183349 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K85133207 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K88742110 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K90370028 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD-K92856060 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD-K94991378 | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-BE(2) | BRD-K97651142 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-K99006945 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD-M00053801 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD1812 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD1835 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | BRD4132 | CTRP2 | 0.0049 | 160.0000 |
|
| SK-N-BE(2) | BRD6340 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD6430 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD8899 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD8958 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | BRD9647 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | BRD9876 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | BRD9876:MK-1775 (4:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | brefeldin A | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | brivanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | C6-ceramide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Cabozantinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | canertinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Carboplatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | carboplatin:etoposide (40:17 mol-mol) | CTRP2 | 0.0014 | 48.0000 |
|
| SK-N-BE(2) | carboplatin:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | CAY10576 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | CAY10594 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | CAY10618 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | CBB-1007 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | CCT036477 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | CD-1530 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | CD-437 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | Cediranib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ceranib-2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | cerulenin | CTRP2 | 0.0045 | 150.0000 |
|
| SK-N-BE(2) | Ch-55 | CTRP2 | 0.0020 | 33.0000 |
|
| SK-N-BE(2) | CHEMBL1222381 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | CHEMBL374350 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | CHIR-99021 | CTRP2 | 0.0097 | 80.0000 |
|
| SK-N-BE(2) | chlorambucil | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | CHM-1 | CTRP2 | 0.0005 | 16.0000 |
|
| SK-N-BE(2) | CI-976 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | ciclopirox | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ciclosporin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | CID-5951923 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | clofarabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | COL-3 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Compound 1541A | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | compound 1B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Compound 23 citrate | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Compound 7d-cis | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | CR-1-31B | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Crizotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | crizotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | cucurbitacin I | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | curcumin | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | cytarabine hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | cytochalasin B | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Dabrafenib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Dacarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Dactolisib | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | Daporinad | CTRP2 | 0.0001 | 2.0000 |
|
| SK-N-BE(2) | Dasatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | DBeQ | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Decitabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | decitabine:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | decitabine:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | dexamethasone | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Dinaciclib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Docetaxel | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | docetaxel:tanespimycin (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | Doramapimod | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Doxorubicin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | doxorubicin:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | elocalcitol | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Entinostat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | epigallocatechin-3-monogallate | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-BE(2) | erastin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Erlotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | erlotinib:PLX-4032 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | etomoxir | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-BE(2) | Etoposide | CTRP2 | 0.0009 | 28.0000 |
|
| SK-N-BE(2) | ETP-46464 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Fedratinib | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | fingolimod | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | fluorouracil | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | fluvastatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Foretinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | FQI-2 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | fumonisin B1 | CTRP2 | 0.0150 | 500.0000 |
|
| SK-N-BE(2) | GANT-61 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GDC-0879 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Gefitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Gemcitabine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | GMX-1778 | CTRP2 | 0.0000 | 0.3000 |
|
| SK-N-BE(2) | gossypol | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | GSK-3 inhibitor IX | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GSK-J4 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GSK1059615 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | GSK2636771 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GSK4112 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GSK461364 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | GW-405833 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | GW843682X | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | HBX-41108 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | HC-067047 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | HLI 373 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | hyperforin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | I-BET-762 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | I-BET151 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Ibrutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | IC-87114 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Idelalisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Imatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | importazole | CTRP2 | 0.0061 | 200.0000 |
|
| SK-N-BE(2) | indisulam | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | IPR-456 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Irinotecan | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | isoevodiamine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | isonicotinohydroxamic acid | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ISOX | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ISOX:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | istradefylline | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | itraconazole | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | IU1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | JQ-1:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | JQ-1:MK-0752 (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | JQ-1:navitoclax (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | JQ-1:UNC0638 (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | JQ-1:vorinostat (2:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | JQ1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | JW-480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | JW-74 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KH-CB19 | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | KHS101 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Ki8751 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Ko-143 | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | KPT185 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KU 0060648 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | KU-0063794 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KU-55933 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KU-60019 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KW-2449 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | KX2-391 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | L-685458 | CTRP2,CCLE | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | Lapatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | LBH-589 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | LBW242 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | LE-135 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Lenvatinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | leptomycin B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Linifanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Linsitinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | lomeguatrib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | lovastatin acid | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | LRRK2-IN-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | LY-2183240 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | manumycin A | CTRP2 | 0.0009 | 30.0000 |
|
| SK-N-BE(2) | marinopyrrole A | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Masitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Mdivi-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Merck60 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Methotrexate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | methylstat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | MGCD-265 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | MI-2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | MIRA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | mitomycin | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | MK-0752 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | MK-1775 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | MK-2206 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ML006 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | ML030 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ML050 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ML162 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ML210 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | ML239 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ML311 | CTRP2 | 0.0010 | 66.0000 |
|
| SK-N-BE(2) | ML320 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ML334 diastereomer | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | MLN2238 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | MLN2480 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | momelotinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | myricetin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | N9-isopropylolomoucine | CTRP2 | 0.0120 | 400.0000 |
|
| SK-N-BE(2) | nakiterpiosin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | narciclasine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Navitoclax | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:birinapant (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:piperlongumine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:pluripotin (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:PLX-4032 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | navitoclax:sorafenib (1:1 mol-mol) | CTRP2 | 0.0015 | 50.0000 |
|
| SK-N-BE(2) | necrostatin-1 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | necrostatin-7 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | necrosulfonamide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Nelarabine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | neratinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | niclosamide | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Nilotinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | nintedanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NPC-26 | CTRP2 | 0.0012 | 40.0000 |
|
| SK-N-BE(2) | NSC 74859 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | NSC23766 | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | NSC30930 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NSC48300 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NSC632839 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | NSC95397 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Nutlin-3a | CTRP2,CCLE | 0.0025 | 150.0000 |
|
| SK-N-BE(2) | NVP-231 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NVP-ADW742 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NVP-BSK805 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | NVP-TAE684 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | O-6-benzylguanine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Obatoclax Mesylate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Olaparib | CTRP2 | 0.0045 | 150.0000 |
|
| SK-N-BE(2) | oligomycin A | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | omacetaxine mepesuccinate | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | OSI-027 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | OSI-930 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ouabain | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | Oxaliplatin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PAC-1 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Paclitaxel | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Palbociclib | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | palmostatin B | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | pandacostat | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Panobinostat | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | parbendazole | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Parthenolide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Pazopanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PD 153035 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | PD0325901 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | PD318088 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PDMP | CTRP2 | 0.0065 | 210.0000 |
|
| SK-N-BE(2) | Pevonedistat | CTRP2 | 0.0045 | 37.0000 |
|
| SK-N-BE(2) | PF-184 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PF-3758309 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PF-4800567 hydrochloride | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PF-573228 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PF-750 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | PHA-665752 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | PHA-793887 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | phloretin | CTRP2 | 0.0180 | 590.0000 |
|
| SK-N-BE(2) | PI-103 | CTRP2 | 0.0045 | 37.0000 |
|
| SK-N-BE(2) | Pictilisib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | pifithrin-alpha | CTRP2 | 0.0071 | 230.0000 |
|
| SK-N-BE(2) | pifithrin-mu | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | PIK-93 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Piperlongumine | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | piperlongumine:MST-312 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | pitstop2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | PL-DI | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Platin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | pluripotin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | PLX-4032 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | PLX-4720 | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | PRIMA-1 | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | PRL-3 Inhibitor I | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | procarbazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | prochlorperazine | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | purmorphamine | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | PX-12 | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-BE(2) | PYR-41 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | pyrazolanthrone | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Quizartinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | R428 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | RAF265 | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Rapamycin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Regorafenib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Repligen 136 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | RG-108 | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | rigosertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | RITA | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | RO4929097 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Ruxolitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | salermide | CTRP2 | 0.0120 | 400.0000 |
|
| SK-N-BE(2) | salermide:PLX-4032 (12:1 mol-mol) | CTRP2 | 0.0066 | 220.0000 |
|
| SK-N-BE(2) | Saracatinib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SB-225002 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | SB-431542 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SB-525334 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SB-743921 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | SCH-529074 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | SCH-79797 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | Selisistat | CTRP2 | 0.0024 | 80.0000 |
|
| SK-N-BE(2) | Selumetinib | CTRP2,CCLE | 0.0025 | 270.0000 |
|
| SK-N-BE(2) | selumetinib:BRD-A02303741 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | selumetinib:decitabine (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | selumetinib:GDC-0941 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | selumetinib:JQ-1 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | selumetinib:MK-2206 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | selumetinib:navitoclax (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | selumetinib:piperlongumine (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | selumetinib:PLX-4032 (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | selumetinib:tretinoin (2:1 mol-mol) | CTRP2 | 0.0061 | 100.0000 |
|
| SK-N-BE(2) | selumetinib:UNC0638 (4:1 mol-mol) | CTRP2 | 0.0051 | 170.0000 |
|
| SK-N-BE(2) | selumetinib:vorinostat (8:1 mol-mol) | CTRP2 | 0.0046 | 150.0000 |
|
| SK-N-BE(2) | semagacestat | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Sepantronium bromide | CTRP2 | 0.0000 | 1.0000 |
|
| SK-N-BE(2) | Serdemetan | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | serdemetan:SCH-529074 (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | SGX-523 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SID 26681509 | CTRP2 | 0.0090 | 300.0000 |
|
| SK-N-BE(2) | sildenafil | CTRP2 | 0.0160 | 530.0000 |
|
| SK-N-BE(2) | silmitasertib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | simvastatin | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | sirolimus:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | SJ-172550 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | skepinone-L | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SKI-II | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | SMER-3 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SN-38 | CTRP2 | 0.0000 | 1.3000 |
|
| SK-N-BE(2) | SNS-032 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SNX-2112 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | SNX-2112:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | Sorafenib | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | sotrastaurin | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | spautin-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Sphingosine Kinase 1 Inhibitor II | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | SR-II-138A | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | SR1001 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SR8278 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | STF-31 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SU11274 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Sunitinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | SZ4TA2 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | tacedinaline | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | tacrolimus | CTRP2 | 0.0023 | 74.0000 |
|
| SK-N-BE(2) | tamatinib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Tamoxifen | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-BE(2) | tandutinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Tanespimycin | CTRP2,CCLE | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | tanespimycin:bortezomib (250:1 mol-mol) | CTRP2 | 0.0005 | 17.0000 |
|
| SK-N-BE(2) | tanespimycin:gemcitabine (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Telomerase Inhibitor IX | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Temozolomide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | TG-100-115 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | TGX221 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Thalidomide | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | tipifarnib-P1 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | tivantinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Tivozanib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | TKI258 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | Topotecan | CTRP2,CCLE | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | tosedostat | CTRP2 | 0.0081 | 270.0000 |
|
| SK-N-BE(2) | TPCA-1 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Trametinib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Tretinoin | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | tretinoin:carboplatin (2:1 mol-mol) | CTRP2 | 0.0030 | 100.0000 |
|
| SK-N-BE(2) | tretinoin:navitoclax (4:1 mol-mol) | CTRP2 | 0.0025 | 83.0000 |
|
| SK-N-BE(2) | trifluoperazine | CTRP2 | 0.0041 | 33.0000 |
|
| SK-N-BE(2) | triptolide | CTRP2 | 0.0000 | 0.3000 |
|
| SK-N-BE(2) | TW 37 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | UNC0321 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | UNC0638 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | UNC0638:navitoclax (1:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | VAF-347 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | valdecoxib | CTRP2 | 0.0180 | 600.0000 |
|
| SK-N-BE(2) | vandetanib | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Veliparib | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | Venetoclax | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | VER-155008 | CTRP2 | 0.0011 | 37.0000 |
|
| SK-N-BE(2) | Vincristine | CTRP2 | 0.0041 | 130.0000 |
|
| SK-N-BE(2) | vorapaxar | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | Vorinostat | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | vorinostat:carboplatin (1:1 mol-mol) | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | vorinostat:navitoclax (4:1 mol-mol) | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | VU0155056 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | VX-680 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | WAY-362450 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | WP1130 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | WZ4002 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | WZ8040 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | XL765 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | YK-4-279 | CTRP2 | 0.0010 | 33.0000 |
|
| SK-N-BE(2) | YL54 | CTRP2 | 0.0020 | 66.0000 |
|
| SK-N-BE(2) | ZD-6474 | CCLE | 0.0025 | 8.0000 |
|
| SK-N-BE(2) | zebularine | CTRP2 | 0.0180 | 590.0000 |
|
| SK-N-BE(2) | ZSTK474 | CTRP2 | 0.0020 | 66.0000 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC